IDH2 and acute myeloid leukemia: This caveat might be because of early proliferation associated with differentiation, which we observed within other AML models, such as IDH2-mutated AML.6 After 2.5-week treatment, whole blood cell count in vehicle-treated mice were 25–65k/μL, but those in SP2509-treated mice were largely normal (Fig. 6j).